Lantern Pharma (LTRN) Amortizatization of Intangibles (2022)
Lantern Pharma's (LTRN) quarterly Amortizatization of Intangibles came in at -$5341.0 in Q4 2022, down 127.11% on a QoQ basis from $19701.0 in Q3 2022.
Lantern Pharma (LTRN) Amortizatization of Intangibles (2022) Analysis & Trends
Lantern Pharma (LTRN) has 1 years of Amortizatization of Intangibles data on file, last reported at -$5341.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Lantern Pharma | 26.05 Mn | 26.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -5,341.00 |
| Dec 31, 2022 | -5,341.00 |
| Sep 30, 2022 | 19,701.00 |
| Sep 30, 2022 | 19,701.00 |